It was hypothesized that Aβ+ in this sample with early pathology would be associated with an accelerated pattern of AD-like atrophy that worsened with longer durations of Aβ+, controlling for individuals who became tau-positive within their observation period. The gene discussed is MAPT; the disease is Alzheimer disease.